Analysts: Boston Scientific Corp (BSX)

BSX on New York Consolidated

14.59USD
28 Jan 2015
Change (% chg)

$-0.15 (-1.02%)
Prev Close
$14.74
Open
$14.76
Day's High
$14.88
Day's Low
$14.56
Volume
6,854,345
Avg. Vol
12,395,618
52-wk High
$15.02
52-wk Low
$11.10

Search Stocks

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform 0.21 December 28 Jan 2015

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 8 7 7 7
(2) OUTPERFORM 8 7 7 7
(3) HOLD 9 11 11 11
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.04 2.16 2.16 2.16

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Mar-15 13 1,836.31 1,880.00 1,793.00 1,905.69
Quarter Ending Jun-15 13 1,894.66 1,956.00 1,703.40 1,969.45
Year Ending Dec-15 25 7,609.44 7,814.00 7,372.00 7,726.27
Earnings (per share)
Quarter Ending Mar-15 14 0.21 0.25 0.19 0.14
Quarter Ending Jun-15 14 0.22 0.24 0.21 0.19
Year Ending Dec-15 25 0.90 0.95 0.84 0.62
LT Growth Rate (%) 6 10.56 14.00 8.60 14.29

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-14 1,818.96 1,846.00 27.04 1.49
Quarter Ending Jun-14 1,865.70 1,873.00 7.30 0.39
Quarter Ending Mar-14 1,795.35 1,774.00 21.35 1.19
Quarter Ending Dec-13 1,826.26 1,838.00 11.74 0.64
Quarter Ending Sep-13 1,734.46 1,735.00 0.54 0.03
Earnings (per share)
Quarter Ending Sep-14 0.20 0.20 0.00 2.25
Quarter Ending Jun-14 0.19 0.21 0.02 8.58
Quarter Ending Mar-14 0.18 0.20 0.02 13.31
Quarter Ending Dec-13 0.13 0.13 0.00 3.67
Quarter Ending Sep-13 0.09 0.10 0.01 8.11

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Mar-15 1,836.31 1,836.31 1,849.79 1,855.89 1,905.69
Quarter Ending Jun-15 1,894.66 1,894.66 1,908.67 1,914.93 1,969.45
Year Ending Dec-15 7,609.44 7,615.17 7,669.56 7,683.89 7,726.27
Earnings (per share)
Quarter Ending Mar-15 0.21 0.21 0.21 0.21 0.14
Quarter Ending Jun-15 0.22 0.22 0.22 0.22 0.19
Year Ending Dec-15 0.90 0.90 0.90 0.91 0.62

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Mar-15 0 0 0 5
Quarter Ending Jun-15 0 0 0 5
Year Ending Dec-15 0 1 0 10
Earnings
Quarter Ending Mar-15 0 0 1 0
Quarter Ending Jun-15 0 0 2 1
Year Ending Dec-15 0 0 1 5

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks